The CINSARC signature as a prognostic marker for clinical outcome in multiple neoplasms

Archive ouverte

Lesluyes, Tom | Delespaul, Lucile | Coindre, Jean-Michel | Chibon, Frédéric

Edité par CCSD ; Nature Publishing Group -

International audience. Abstract We previously reported the CINSARC signature as a prognostic marker for metastatic events in soft tissue sarcomas, breast carcinomas and lymphomas through genomic instability, acting as a major factor for tumor aggressiveness. In this study, we used a published resource to investigate CINSARC enrichment in poor outcome-associated genes at pan-cancer level and in 39 cancer types. CINSARC outperformed more than 15,000 defined signatures (including cancer-related), being enriched in top-ranked poor outcome-associated genes of 21 cancer types, widest coverage reached among all tested signatures. Independently, this signature demonstrated significant survival differences between risk-groups in 33 published studies, representing 17 tumor types. As a consequence, we propose the CINSARC prognostication as a general marker for tumor aggressiveness to optimize the clinical managements of patients.

Consulter en ligne

Suggestions

Du même auteur

Genome remodeling upon mesenchymal tumor cell fusion contributes to tumor progression and metastatic spread

Archive ouverte | Lartigue, Lydia | CCSD

International audience

ATRX Alteration Contributes to Tumor Growth and Immune Escape in Pleomorphic Sarcomas

Archive ouverte | Darmusey, Lucie | CCSD

International audience. Whole genome and transcriptome sequencing of a cohort of 67 leiomyosarcomas has been revealed ATRX to be one of the most frequently mutated genes in leiomyosarcomas after TP53 and RB1. While ...

Recurrent \textitTRIO Fusion in Nontranslocation\textendashRelated Sarcomas

Archive ouverte | Delespaul, Lucile | CCSD

International audience

Chargement des enrichissements...